Cite
HARVARD Citation
Hu, Q. et al. (2022). The efficacy and safety of adding on or switching to peginterferon α‐2b in HBeAg‐positive chronic hepatitis B patients with long‐term entecavir treatment: a multicentre randomised controlled trial. Alimentary pharmacology & therapeutics. 56 (9), pp. 1394-1407. [Online].